Differentiation of reinfection from relapse in recurrent Lyme disease

New England Journal of Medicine

Volumn 367, Issue 20, 2012, Pages 1883-1890

  Nadelman, Robert B ^a   Hanincová, Klára ^a   Mukherjee, Priyanka ^a   Liveris, Dionysios ^a   Nowakowski, John ^a   McKenna, Donna ^a   Brisson, Dustin ^b   Cooper, Denise ^a   Bittker, Susan ^a   Madison, Gul ^a   Holmgren, Diane ^a   Schwartz, Ira ^a   Wormser, Gary P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; DNA 16S; DNA 23S;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA SEQUENCE; DRUG EFFECT; DRUG TREATMENT FAILURE; ERYTHEMA CHRONICUM MIGRANS; FEMALE; GENE IDENTIFICATION; GENETIC CODE; GENOTYPE; HUMAN; HUMAN TISSUE; LYME DISEASE; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OUTER SURFACE PROTEIN C GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; TREATMENT DURATION;

EID: 84868697894     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1114362     Document Type: Article

References (38)

1. Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am 2008;22:235-60.
2. Steere AC, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1983;99:76-82.
3. Nowakowski J, McKenna D, Nadelman RB, et al. Failure of treatment with cephalexin for Lyme disease. Arch Fam Med 2000;9:563-7.
4. Nowakowski J, Nadelman RB, Sell R, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med 2003;115:91-6.
5. Krause PJ, Foley DT, Burke GS, Christianson D, Closter L, Spielman A. Reinfection and relapse in early Lyme disease. Am J Trop Med Hyg 2006;75:1090-4.
6. Nadelman RB, Wormser GP. Reinfection in patients with Lyme disease. Clin Infect Dis 2007;45:1032-8.
7. Nowakowski J, Schwartz I, Nadelman RB, Liveris D, Aguero-Rosenfeld M, Wormser GP. Culture-confirmed infection and reinfection with Borrelia burgdorferi. Ann Intern Med 1997;127:130-2.
8. Golde WT, Robinson-Dunn B, Stobierski MG, et al. Culture-confirmed reinfection of a person with different strains of Borrelia burgdorferi sensu stricto. J Clin Microbiol 1998;36:1015-9.
9. Wormser GP, Schwartz I. Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev 2009;22:387-95.
10. Vaz A, Glickstein L, Field JA, et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 2001;69:7437-44.
11. Wormser GP, Brisson D, Liveris D, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis 2008;198:1358-64.
12. Brisson D, Vandermause MF, Meece JK, Reed KD, Dykhuizen DE. Evolution of northeastern and midwestern Borrelia burgdorferi, United States. Emerg Infect Dis 2010;16:911-7.
13. Wormser GP, Liveris D, Nowakowski J, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 1999;180:720-5.
14. Schwartz I, Wormser GP, Schwartz JJ, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992;30:3082-8.
15. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-134.
16. Brisson D, Dykhuizen DE. ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics 2004;168:713-22.
17. Liveris D, Wang G, Girao G, et al. Quantity of Borrelia burgdorferi detected in 2 mm skin samples of erythema migrans lesions: correlation with clinical and laboratory findings. J Clin Microbiol 2002;40:1249-53.
18. Wang G, van Dam AP, Dankert J. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with Lyme borreliosis. J Clin Microbiol 1999;37:3025-8.
19. Margos G, Gatewood AG, Aanensen DM, et al. MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A 2008;105:8730-5.
20. Hanincová K, Liveris D, Sandigursky S, Wormser GP, Schwartz I. Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol 2008;74:5008-14.
21. Melski JW, Reed KD, Mitchell PD, Barth GD. Primary and secondary erythema migrans in central Wisconsin. Arch Dermatol 1993;129:709-16.
22. Malane MS, Grant-Kels JM, Feder HM Jr, Luger SW. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 1991;114:490-8.
23. Nadelman RB, Wormser GP. Reinfection in patients with Lyme disease. Clin Infect Dis 2008;46:950-1.
24. Seinost G, Golde WT, Berger BW, et al. Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease. Arch Dermatol 1999;135:1329-33.
25. Liveris D, Varde S, Iyer R, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol 1999;37:565-9.
26. Jones KL, Glickstein LJ, Damle N, Sikand VK, McHugh G, Steere AC. Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J Clin Microbiol 2006;44:4407-13.
27. Qiu W-G, Dykhuizen DE, Acosta MS, Luft BJ. Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the northeastern United States. Genetics 2002;160:833-49.
28. Crowder CD, Matthews HE, Schutzer S, et al. Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe. PLoS One 2010;5(5):e10650.
29. Guttman DS, Wang PW, Wang IN, Bosler EM, Luft BJ, Dykhuizen DE. Multiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as revealed by single-strand conformation polymorphism analysis. J Clin Microbiol 1996;34:652-6.
30. Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 1999;151:15-30.
31. Berger BW, Johnson RC, Kodner C, Coleman L. Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. J Am Acad Dermatol 1992;27:34-7.
32. Nadelman RB, Nowakowski J, Forseter G, et al. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Am J Med 1993;94:583-8.
33. Falco RC, McKenna DF, Daniels TJ, et al. Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans. Am J Epidemiol 1999;149:771-6.
34. Seinost G, Dykhuizen DE, Dattwyler RJ, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999;67:3518-24.
35. Dykhuizen DE, Brisson D, Sandigursky S, et al. The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg 2008;78:806-10.
36. Brisson D, Dykhuizen DE. A modest model explains the distribution and abundance of Borrelia burgdorferi strains. Am J Trop Med Hyg 2006;74:615-22.
37. Nowakowski J, Schwartz I, Liveris D, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001;33:2023-7.
38. Probert WS, Crawford M, Cadiz RB, LeFebvre RB. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis 1997;175:400-5.